<article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         dtd-version="1.0"
         article-type="research-article">
   <front>
      <journal-meta>
         <journal-id journal-id-type="jstor">intejhealcarefin</journal-id>
         <journal-id journal-id-type="jstor">j100925</journal-id>
         <journal-title-group>
            <journal-title>International Journal of Health Care Finance and Economics</journal-title>
         </journal-title-group>
         <publisher>
            <publisher-name>Springer Science+Business Media</publisher-name>
         </publisher>
         <issn pub-type="ppub">13896563</issn>
         <issn pub-type="epub">15736962</issn>
         <custom-meta-group/>
      </journal-meta>
      <article-meta>
         <article-id pub-id-type="jstor">30221736</article-id>
         <article-id pub-id-type="pub-doi">10.1007/s10754-007-9014-y</article-id>
         <title-group>
            <article-title>The Financing and Organization of Medical Care for Patients with End-stage Renal Disease in Sweden</article-title>
         </title-group>
         <contrib-group>
            <contrib>
               <string-name>
                  <given-names>Björn</given-names>
                  <surname>Wikström</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Michael</given-names>
                  <surname>Fored</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Margaret A.</given-names>
                  <surname>Eichleay</surname>
               </string-name>
            </contrib>
            <contrib>
               <string-name>
                  <given-names>Stefan H.</given-names>
                  <surname>Jacobson</surname>
               </string-name>
            </contrib>
         </contrib-group>
         <pub-date>
            <day>1</day>
            <month>12</month>
            <year>2007</year>
         </pub-date>
         <volume xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">7</volume>
         <issue xmlns:oasis="http://docs.oasis-open.org/ns/oasis-exchange/table">4</issue>
         <issue-id>i30221732</issue-id>
         <fpage>269</fpage>
         <lpage>281</lpage>
         <permissions>
            <copyright-statement>Copyright 2007 Springer Science+Business Media, LLC</copyright-statement>
         </permissions>
         <self-uri xlink:href="https://www.jstor.org/stable/30221736"/>
         <abstract>
            <p>The total health care expenditure as a percentage of the gross domestic product in Sweden is 9.2%, and health care is funded by global budgets almost entirely through general taxation. The prevalence rate of end-stage renal disease (ESRD) in Sweden is 756 per million. Fifty-two percent of ESRD patients have a functioning transplant. Ahnost all ESRD treatment facilities are public. Compared with other Dialysis Outcomes and Practice Patterns Study (DOPPS) countries, the salaries for both nephrologists and professional dialysis unit staff are low. Sweden's high cost per ESRD patient, relative to other DOPPS countries, may be a result of expensive and frequent hospitalizations and aggressive anemia treatment strategies.</p>
         </abstract>
         <kwd-group>
            <kwd>End-stage kidney disease</kwd>
            <kwd>Health care costs</kwd>
            <kwd>Economics</kwd>
            <kwd>Renal replacement therapy</kwd>
            <kwd>Dialysis</kwd>
            <kwd>Reimbursement</kwd>
            <kwd>Sweden</kwd>
            <kwd>I10</kwd>
            <kwd>I11</kwd>
            <kwd>I12</kwd>
            <kwd>I18</kwd>
         </kwd-group>
         <custom-meta-group>
            <custom-meta>
               <meta-name>lang</meta-name>
               <meta-value>eng</meta-value>
            </custom-meta>
         </custom-meta-group>
      </article-meta>
   </front>
   <back>
      <ref-list>
         <title>References</title>
         <ref id="d17e220a1310">
            <mixed-citation id="d17e224" publication-type="other">
Ashton, T., &amp; Marshall, M. R. (2007). The organization and financing of dialysis and kidney transplan-
tation services in New Zealand. International Journal of Health Care Finance and Economics. DOI:
10.1007/s10754-007-9023-x</mixed-citation>
         </ref>
         <ref id="d17e237a1310">
            <mixed-citation id="d17e241" publication-type="other">
Cass, A., Chadban, S., Craig, J., Howard, K., McDonald, S., Salkeld, G., &amp; White, S. (2006). The economic
impact of end stage kidney disease in Australia. Sydney: The George Institute for International Health.</mixed-citation>
         </ref>
         <ref id="d17e251a1310">
            <mixed-citation id="d17e255" publication-type="other">
Dor, A., Pauly. M. V., Eichleay, M. A., &amp; Held, P. J. (2007). End-stage renal disease and econimic incentives:
The International Study of Health Care Organization and Financing (ISHCOF). International Journal of
Health Care Finance and Economics. DOI: 10.1007/s 10754-007-9024-9</mixed-citation>
         </ref>
         <ref id="d17e268a1310">
            <mixed-citation id="d17e272" publication-type="other">
Durand-Zaleski, I., Combe, C., &amp; Lang, P. (2007). International Study of Health Care Organization and Financ-
ing for end-stage renal disease in France. International Journal of Health Care Finance and Economics.
DOI: 10.1007/s10754-007-9025-8</mixed-citation>
         </ref>
         <ref id="d17e286a1310">
            <mixed-citation id="d17e290" publication-type="other">
Hirth, R. A. (2007). The organization and financing of dialysis and kidney transplant care in the
United States of America. International Journal of Health Care Finance and Economics. DOI:
10. 1007/s10754-007-9019-6</mixed-citation>
         </ref>
         <ref id="d17e303a1310">
            <mixed-citation id="d17e307" publication-type="other">
Jacobson, S. H., Czekalski, S., Hannedouche, T., Loureiro, A., Martin-Malo, A., Papadimitriou, M., Ronco,
C., Vanholder, R., Wizemann, V., &amp; Locatelli, F. (2004). Modifiable cardiovascular risk factors: Baseline
results of the MPO Study. Journal of the American Society of Nephrology, 15, 614A.</mixed-citation>
         </ref>
         <ref id="d17e320a1310">
            <mixed-citation id="d17e324" publication-type="other">
Kjellstrand, C., &amp; Moody, H. (1994). Hemodialysis in Canada: A first-class medical crisis. Canadian Medical
Association Journal, 150, 1067-1071.</mixed-citation>
         </ref>
         <ref id="d17e334a1310">
            <mixed-citation id="d17e338" publication-type="other">
Kjellstrand, C. (1996). High-technology medicine and the old: The dialysis example. Journal of Internal
Medicine, 239, 195-210.</mixed-citation>
         </ref>
         <ref id="d17e348a1310">
            <mixed-citation id="d17e352" publication-type="other">
Kleophas, W., &amp; Reichel, H. (2007). International Study of Health Care Organization and Financing: Devel-
opment of renal replacement therapy in Germany. International Journal of Health Care Finance and
Economics. DOI: 10. 1007/s 10754-007-9020-0</mixed-citation>
         </ref>
         <ref id="d17e365a1310">
            <mixed-citation id="d17e369" publication-type="other">
Lee, H., Manns, B. J., Taub, K., Ghali, W., Dean, S., Johnson, D., &amp; Donaldson, C. (2002). Cost analysis
of ongoing care of patients with end stage renal disease: The impact of dialysis modality and dialysis
access. American Journal of Kidney Diseases, 40(3), 611-622.</mixed-citation>
         </ref>
         <ref id="d17e383a1310">
            <mixed-citation id="d17e387" publication-type="other">
Locatelli, F., Hannedouche, T., Jacobson, S. H., La Greca, G., Loureiro, A., Martin-Malo, A., Papadimitriou,
M., Vanholder, R., &amp; the MPO Study Group. (2002). Risk factors for cardiovascular diseases in patients
starting dialysis in northern and southern Europe: Results from the MPO Study. Nephrology Dialysis
Transplantation, 17, 11. Retrieved March 29, 2007 at http://www.abstracts2view.com/era/</mixed-citation>
         </ref>
         <ref id="d17e403a1310">
            <mixed-citation id="d17e407" publication-type="other">
Luño, J. (2007). The organization and financing of end-stage renal disease in Spain. International Journal of
Health Care Finance and Economics. DOI: 10.1007/s10754-007-9021-z</mixed-citation>
         </ref>
         <ref id="d17e417a1310">
            <mixed-citation id="d17e421" publication-type="other">
Nicholson, T., &amp; Roderick, P. (2007). International Study of Health Care Organization and Financing of Renal
Services in England and Wales. Intenzational Journal of Health Care Finance and Economics. DOI:
10. 1007/s 10754-007-9015-x</mixed-citation>
         </ref>
         <ref id="d17e434a1310">
            <mixed-citation id="d17e438" publication-type="other">
Organisation for Economic Co-operation and Development (OECD). (2004). Total expenditure for in-patient
care. OECD Health Data 2004 (1st edn). Version 06/07/2004. Paris: Organization for Economic Coop-
eration and Development.</mixed-citation>
         </ref>
         <ref id="d17e451a1310">
            <mixed-citation id="d17e455" publication-type="other">
OECD. (2005). OECD in figures-2005 edition: Health spending and resources. Paris: Organization for Eco-
nomic Cooperation and Development.</mixed-citation>
         </ref>
         <ref id="d17e465a1310">
            <mixed-citation id="d17e469" publication-type="other">
OECD. (2006). Purchasing power parities (PPPs) for OECD countries 1980-2005. Retrieved October 14,
2006, from http://www.oecd.org/statisticsdata/0,2643,en 2649_34357_1_119656_1_1_1,00.html.</mixed-citation>
         </ref>
         <ref id="d17e480a1310">
            <mixed-citation id="d17e484" publication-type="other">
Pisoni, R. L., Bragg-Gresham, J. L., Young, E. W., Akizawa, T., Asano, Y., Locatelli, F., Bommer, J., Cruz, J.
M., Kerr, P. G., Mendelssohn, D. C., Held, P. J., &amp; Port, F. K. (2004). Anemia management and outcomes
from 12 countries in the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of
Kidney Diseases, 44(1), 94-111.</mixed-citation>
         </ref>
         <ref id="d17e500a1310">
            <mixed-citation id="d17e504" publication-type="other">
Pontoriero, G., Pozzoni, P., Del Vecchio, L., &amp; Locatelli, F. (2007). International Study of Health Care Orga-
nization and Financing of renal replacement therapy in Italy: An evolving reality. International Journal
of Health Care Finance and Economics. DOI: 10. 1007/s10754-007-9016-9</mixed-citation>
         </ref>
         <ref id="d17e517a1310">
            <mixed-citation id="d17e521" publication-type="other">
Rayner, H., Pisoni, R. L., Bommer, J., Canaud, B., Hecking, E., Locatelli, F., Piera, L., Bragg-Gresham, J. L.,
Feldman, H. I., Goodkin, D. A., Gillespie, B., Wolfe, R. A., Held, P. J., &amp; Port, F. K. (2004). Mortality and
hospitalization in haemodialysis patients in five European countries: Results from the Dialysis Outcomes
and Practice Patterns Study (DOPPS). Nephrology Dialysis and Transplantation, 19, 108-120.</mixed-citation>
         </ref>
         <ref id="d17e537a1310">
            <mixed-citation id="d17e541" publication-type="other">
Scandiatransplant (2003). Scandiatransplant organ procurement and transplant activity 2003. Retrieved Feb-
ruary 19, 2007, from http://www.scandiatransplant.org/tx_newsletter2003.htm.</mixed-citation>
         </ref>
         <ref id="d17e551a1310">
            <mixed-citation id="d17e555" publication-type="other">
Statistiska centralbyrån (SCB) (2003). Sveriges officiella statistik: Statistiska meddelanden. Retreived Febru-
ary 26, 2007, from www.scb.se/Statistik/OE/OEO101/2003M00/OE18SM0301.pdf</mixed-citation>
         </ref>
         <ref id="d17e565a1310">
            <mixed-citation id="d17e569" publication-type="other">
Svenskt Register för Aktiv Uremivård (SRAU) (2003). Aktiv uremivård i sverige: 1991-2002.
Retrieved February 19, 2007, from http://www.socialstyrelsen.se/NR/rdonlyres/AC IA8C40-F4B8-4297-
A24B-E7671 B8CC31E/0/kva023r03.pdf</mixed-citation>
         </ref>
         <ref id="d17e583a1310">
            <mixed-citation id="d17e587" publication-type="other">
U.S. Renal Data System (USRDS) (2005). United States Renal Data System 2005 annual data report: Atlas of
end-stage renal disease in the United States. Bethesda: National Institutes of Health, National Institute
of Diabetes and Digestive and Kidney Diseases.</mixed-citation>
         </ref>
         <ref id="d17e600a1310">
            <mixed-citation id="d17e604" publication-type="other">
Van Biesen, W., Lameire, N., Peeters, P., &amp; Vanholder, R. (2007). Belgium's mixed private/public health care
system and its impact on the cost of end-stage renal disease. International Journal of Health Care Finance
and Economics. DOI: 10.1007/s10754-007-9013-z</mixed-citation>
         </ref>
         <ref id="d17e617a1310">
            <mixed-citation id="d17e621" publication-type="other">
World Bank (2005). 2005 World Development Indicators. Washington DC: The World Bank Group.</mixed-citation>
         </ref>
      </ref-list>
   </back>
</article>
